Global Market for Metabolomics is Projected to Reach US$1.4 Billion by the Year 2020

Increasing R&D Investments & Expanding Applications to Fuel Growth in the Global Metabolomics Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Metabolomics markets. Global market for Metabolomics is projected to reach US$1.4 billion by the year 2020, driven by increasing investments in Metabolomics research and rising adoption of the technology in pharmaceutical and biotechnology sectors.

Metabolomics is a dynamic concept and a newly emerging field of omic sciences. Metabolomics is the study of chemical processes involving metabolites and provides information on the chemical fingerprints of various cellular processes. Metabolomics or metabolite profiling provides a more holistic view of the phenotype of organelles, organs, tissues, cells and whole organisms, when compared to DNA, RNA, or protein profile. With proteomic and genomic analysis proving inadequate in offering comprehensive information, researchers are shifting focus onto metabolic profiling to gain detailed insights into the cell’s physiology. Metabolomics has evolved rapidly in recent years in- sync with advances in separation and analysis technologies related to mass spectroscopy (MS) and nuclear magnetic resonance (NMR) based detection techniques.

The market in the coming years will be driven by the increasing volume of clinical trials, rise in toxicological studies, growth of metabolomics data analysis solutions and software, and increasing use of metabolomics as a diagnostic tool for biomarker screening of various diseases. Adoption of metabolomics in drug development will continue to encourage growth in the market. Technological breakthroughs in analytical technologies and advances in data processing and analysis software are expected to further boost growth prospects. Bioinformatics-based metabolomics applications will witness robust growth in pharmaceutical research, clinical research, food and beverage analysis, plant and animal phenotyping, nutrition research, environmental science and biofuel development. With small molecule metabolite profiling offering a deeper understanding of disease mechanism than genetic or protein profiling, metabolomics has become the current spotlight for pharmaceutical and biotech companies. Biomarkers have set the stage for the introduction of personalized medicines that reduce side effects and improve patient outcome.

As stated by the new market research report on Metabolomics, the United States represents the largest market worldwide. The presence of a sophisticated healthcare infrastructure conducive to pharmaceutical R&D is a key factor supporting the country’s dominance. Asia-Pacific ranks as the fastest growing market with a CAGR of 18.4% over the analysis period. Aging population, increase in age-related chronic illnesses, improving healthcare infrastructure, growing number of pharmaceutical and biotech companies, rising demand for improved pharmaceutical products, and increased investments in life science research are factors driving growth in the region.

Major players covered in the report include AB SCIEX, Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Chenomx Inc., Human Metabolome Technologies Inc., LECO Corporation, Metabolon Inc., Metanomics GmbH, Shimadzu Corporation, SiDMAP LLC, Thermo Fisher Scientific Inc., and Waters Corporation, among others.

The research report titled “Metabolomics: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in US dollars for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia-Pacific, Latin America, and Rest of World. The report analyzes the global Metabolomics market by segments such as Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications.